1.
Elewski B, Zirwas M, Kurbasic A, Schneider S, Claxton A, Silverberg J. Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):686-95. Available from: https://jofskin.org/33014/index.php/skin/article/view/1871